Conference Coverage AHA 2016 See All Content See past conferences New Orleans, LA November 12, 2016 November 16, 2016 News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Too little time, or too much—clinical trials in cardiology are beset with the same problems plaguing modern humans. < > PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests Yael L. Maxwell November 16, 2016 Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016 Local Anesthesia for TAVR Is Safe, Gets Patients Home More Quickly: Meta-analysis Todd Neale November 15, 2016 News News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016 News Conference News AHA 2016 Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance L.A. McKeown November 23, 2016 News Conference News AHA 2016 Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis Michael O'Riordan November 22, 2016 News Conference News AHA 2016 “Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients Yael L. Maxwell November 21, 2016 Slides Presentation AHA 2016 FUnctional Testing Underlying REvascularization: The FUTURE trial Presenter: Gilles Rioufol November 15, 2016 Presentation AHA 2016 Arterial Revascularization Trial (ART) Presenter: David P. Taggart November 15, 2016 Presentation AHA 2016 GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound Presenter: Steven E. Nissen November 15, 2016 Presentation AHA 2016 PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy Presenter: Michael Gibson November 15, 2016 @TCTMD Follow Us
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Too little time, or too much—clinical trials in cardiology are beset with the same problems plaguing modern humans.
PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests Yael L. Maxwell November 16, 2016
Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016
Local Anesthesia for TAVR Is Safe, Gets Patients Home More Quickly: Meta-analysis Todd Neale November 15, 2016
News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance L.A. McKeown November 23, 2016
News Conference News AHA 2016 Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis Michael O'Riordan November 22, 2016
News Conference News AHA 2016 “Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients Yael L. Maxwell November 21, 2016
Presentation AHA 2016 FUnctional Testing Underlying REvascularization: The FUTURE trial Presenter: Gilles Rioufol November 15, 2016
Presentation AHA 2016 Arterial Revascularization Trial (ART) Presenter: David P. Taggart November 15, 2016
Presentation AHA 2016 GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound Presenter: Steven E. Nissen November 15, 2016
Presentation AHA 2016 PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy Presenter: Michael Gibson November 15, 2016